Chip design and packaging
Moore's Law has moved into the package.
Chiplets, substrates, test and the design tools around India's new assembly plants.
Kinetic Foundry co-founds companies from Indian research. We work alongside scientists, innovators and researchers, with government programmes, IITs, national labs, industry and venture funds from early stage to late stage, to turn breakthroughs into businesses.
Public capital for deep tech is now large, but it enters once a technology has worked in the lab. Before that, between TRL 2 and TRL 4, research has to become a company: a team, a product and a first buyer. That is the stretch Kinetic Foundry is built for.
Proof of concept. The key function has been shown experimentally. Most ventures we co-found start here.
of global venture capital now goes to deep tech, roughly double its share a decade earlier.
BCG, Nov 2023startups from the IIT Madras incubator alone, valued at over ₹53,000 crore, with 13 M&A exits. Indian labs do build companies.
IIT Madras, Dec 2025of Indian deep-tech funding in 2025, with 91% going to AI. Chips, energy, space, bio and quantum share the rest.
Nasscom-Zinnov, Feb 2026A deep-tech company needs five things at once: the science, public programmes, a lab and test bench, a first industrial buyer, and capital that matches each stage. We bring them together around every venture.
Scientist-founders keep meaningful equity and stay close to the technology. We add the operator, the buyer and the plan.
We license and co-develop IP on standard terms, and use shared test and fabrication facilities before building our own.
Grants and mission funds come first: BIRAC, DST, iDEX and ADITI, ISM's design scheme and the National Quantum Mission, matched to each venture.
We find the anchor customer before the factory. Qualification with a real buyer is the product roadmap.
Ventures graduate to outside investors at TRL 4 and beyond, including RDI-backed fund managers, then growth and late-stage funds.
We focus where public capital is committed, demand is visible and a studio-sized entry point exists below fab-scale or launch-scale spending.
Moore's Law has moved into the package.
Chiplets, substrates, test and the design tools around India's new assembly plants.
What if the battery ran on salt?
Sodium-ion, cell materials, recycling and magnets that cut import dependence.
Cameras see colour. This sees chemistry.
Hyperspectral analytics, payloads and the data products that turn orbit into decisions.
Cheap drones need cheaper shields.
Low-cost radar, RF sensing, interceptors and edge autonomy, built dual-use from day one.
Biofoundries are coming. Strains are the gap.
Engineered strains, enzymes, downstream processing and molecules with named buyers, built on shared biofoundry capacity.
Quantum that ships starts with sensing.
Quantum sensors, secure communication and the photonics, cryogenics and control electronics around them, qualified for real platforms.
Every venture moves through the same gated stages. Each gate has kill criteria, so time and capital go to what the evidence supports.
Screen research against a named buyer problem and a studio-sized entry point.
Match the scientist-founder with an operator CEO. Agree equity and licence terms early.
Reach a lab-validated prototype with grants and shared test facilities.
Test against an anchor customer's specification and sign the first paid pilot.
Raise from outside investors and scale, with the studio as a long-term shareholder.
Pick a sector, a readiness level and who you are. The compass applies our method: the stage you are in, the next gate, what would stop the venture, the capital that fits now and what Kinetic Foundry does at that point.
Our Frontier Tech series covers one technology a day, with sourced numbers and the lab-to-company gap in each.
ISRO's estimate of India's space economy, and its 2033 target. A ₹1,000 crore IN-SPACe fund now writes ₹10–60 crore cheques. The studio-sized entry is payloads, sensors and data, not launch.
The National Quantum Mission runs hubs at IISc, IIT Madras, IIT Bombay and IIT Delhi. Sensing, communication and components have nearer-term buyers than general-purpose quantum computers.
India's bioeconomy was 4.25% of GDP in 2024. BioE3 is setting up shared biofoundries. The missing piece is strains, enzymes and products.
The short answers are below. When live answers are switched on, the panel takes any question and answers using only the facts and sources on this page. If the facts don't cover it, it says so.
Public capital such as the ₹1 lakh crore RDI scheme invests from TRL 4. Before that, between TRL 2 and 4, research has to become a company with a team, a product and a first buyer. A studio co-founds companies in exactly that stretch.
About 20% of global venture capital now goes to deep tech (BCG, 2023). The risk is real, so every stage has kill criteria, grants come before equity and an anchor customer comes before a factory.
91% of India's $2.3B of deep-tech funding in 2025 went to AI (Nasscom-Zinnov). Chips, energy materials, space, bio-manufacturing and quantum share the rest. That gap is where we focus.
Meaningful equity and closeness to the technology. We add an operator CEO, the buyer and the plan, and agree licence terms with the lab early.
Use the Venture Compass above to find your stage, then send a note to our founder, Rahul Pratap Yadav, on LinkedIn.
Researchers with a result at TRL 2 to 4, operators who want to lead a deep-tech company, industry teams with a problem to solve, and investors at every stage. Tell us who you are and we'll prepare a note you can send to our founder, Rahul Pratap Yadav, on LinkedIn.